Here are what the editors at HealthDay consider to be the most important developments in Neurology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Low-Priced Generic Drugs Most Likely to Have Shortages
THURSDAY, Dec. 27, 2018 (HealthDay News) — The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.
Abstract/Full Text (subscription or payment may be required)
Targeted Muscle Reinnervation Can Reduce Phantom Limb Pain
THURSDAY, Dec. 27, 2018 (HealthDay News) — Use of primary targeted muscle reinnervation (TMR) can prevent or reduce pain in below-the-knee amputees, according to a report published online Dec. 27 in Plastic and Reconstructive Surgery.
Abstract/Full Text (subscription or payment may be required)
Oculomotor Response to Head Impacts Studied in Youth Football
THURSDAY, Dec. 27, 2018 (HealthDay News) — Near point of convergence (NPC) values change in response to subconcussive head impacts but begin to normalize over time in high school football players, according to a study published online Dec. 20 in JAMA Ophthalmology.
Abstract/Full Text
Editorial (subscription or payment may be required)
Initiative Can Cut Gender Gap in Medical School Faculty Salaries
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — An institutional gender equity initiative (GEI) can reduce gender-based salary gaps among medical school faculty, according to a study published online Dec. 21 in JAMA Network Open.
Study IDs Risk Factors for Violent Sleep Disorder
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — Rapid eye movement (REM) sleep behavior disorder (RBD) is more common among men, as well as those with psychological distress, mental illness, or posttraumatic stress disorder, according to a study published online Dec. 26 in Neurology.
Abstract/Full Text (subscription or payment may be required)
Risk of Arterial Thromboembolic Events Up Prior to Cancer Diagnosis
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — In older adults, the risk of arterial thromboembolic events begins to increase 150 days before the date of cancer diagnosis and peaks 30 days before, according to a study published online Dec. 21 in Blood.
Abstract/Full Text (subscription or payment may be required)
ACOG: Interpregnancy Period Should Maximize Women’s Health
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — Providers should maximize women’s health during the interpregnancy period, continuing care beyond the immediate postpartum period, according to a consensus report published online Dec. 20 in the American Journal of Obstetrics & Gynecology.
Abstract/Full Text (subscription or payment may be required)
FDA Warns Companies on Unsafe, Unapproved Stem Cell Treatments
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
Frequent TV Watching Linked to Smaller Brain Volume
ADHD Poses Additional Concussion Challenges for Athletes
Extreme Heat Linked to 33 Clinically Reportable Diagnoses
Problematic Social Media Use Linked to Worsening of ADHD Symptoms
High Levels of Light Exposure Linked to Lower Dementia Risk
Neurodegenerative Mortality Elevated for NFL Athletes